(Q43191431)

15 November 2017

0 references

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures (English)

1 reference

15 November 2017

0 references

V Rabenda

1

1 reference

15 November 2017

J-Y Reginster

series ordinal

2

1 reference

15 November 2017

language of work or name

English

0 references

publication date

16 January 2010

1 reference

Osteoporosis International

15 November 2017

published in

1 reference

15 November 2017

volume

21

1 reference

15 November 2017

issue

12

1 reference

15 November 2017

page(s)

1993-2002

1 reference

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

15 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-009-1155-Z

Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-009-1155-Z

Pill count measures of compliance in a drug trial: variability and suitability.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-009-1155-Z

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

21 January 2018

1 reference

12 December 2020

Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials

1 reference

12 December 2020

Compliance with pharmacologic therapy for osteoporosis

1 reference

12 December 2020

Compliance with osteoporosis medications

1 reference

12 December 2020

A meta-analysis of the association between adherence to drug therapy and mortality

1 reference

12 December 2020

The validity of an interview to assess a patient's drug taking

1 reference

12 December 2020

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study

1 reference

12 December 2020

Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Health care costs of women with symptomatic vertebral fractures

1 reference

12 December 2020

Strontium ranelate for preventing and treating postmenopausal osteoporosis

1 reference

12 December 2020

Compliance with osteoporosis drug therapy and risk of fracture

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women

1 reference

12 December 2020

Epidemiology and outcomes of osteoporotic fractures

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

12 December 2020

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

1 reference

12 December 2020

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

12 December 2020

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

1 reference

12 December 2020

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

12 December 2020

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

12 December 2020

Persistence with weekly alendronate therapy among postmenopausal women

1 reference

12 December 2020

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

12 December 2020

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

Calcium plus vitamin D supplementation and the risk of fractures

1 reference

12 December 2020

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

12 December 2020

Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

1 reference

12 December 2020

A model of osteoporosis impact in Switzerland 2000-2020.

1 reference

12 December 2020

Estimating medication persistency using administrative claims data.

1 reference

12 December 2020

S 12911-2 inhibits osteoclastic bone resorption in vitro

1 reference

12 December 2020

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

12 December 2020

Time to stop counting the tablets?

1 reference

12 December 2020

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

1 reference

12 December 2020

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

1 reference

12 December 2020

Burden of major musculoskeletal conditions.

1 reference

12 December 2020

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

10.1007/S00198-009-1155-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

1032243778

0 references

1 reference